The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast. These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or firstname.lastname@example.org) where a researcher can help you pinpoint what you need. Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast.
These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or email@example.com) where a researcher can help you pinpoint what you need.
Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
Search results for "Paxil" ...
Side Effects tells the story of a court case and the personal story that surrounded the making and unmasking of a bestselling drug, Paxil. "It chronicles the lives of two women - a prosecutor and a whistleblower - who exposes the pattern of deception in the research and marketing of Paxil, an antidepressant prescribed to millions of children and adults."
This series uncovered how Texas was medicating foster children with powerful and sometimes dangerous psychotropic drugs. In many cases, these drugs were not necessary and over-prescribed. The children were being systematically medicated due to the mandated use of a program that was designed by "expert consultants" who were also paid consultants for the pharmaceutical industry.
In a six month investigation of the antidepressant manufacturers, PrimeTime Live uncovered a trail of internal documentation revealing efforts to suppress information regarding serious adverse health risks from consumers and the doctors who prescribe these powerful psychoactive medications. Patients, and parents of juvenile patients, suspected that the drug companies were not coming clean about the negative effects of antidepressants.
New York reports on the aggressive marketing of drugs, and antidepressants in particular. The story looks at the techniques used by drug sales representatives to attract doctors' attention to the new medications available on the market. The promotion strategies - including free lunches, vacations and gifts - have convinced many doctors to start prescribing a new drug despite some evidence of potential side effects, the investigation reveals. The article focuses on the sales of the newest antidepressant in the U.S.A., Celexa, originally developed by a small Danish company in 1972. The reporter points to the concerns of Dr. Robert Goodman who has started a 'no-free-lunch' campaign against the practices of the drug sales reps.
Using the PharmaNet patient information database, reporter Ann Rees found that children, from infants to teenagers were receiving quite a bit of "mood" drugs including tranquilizers, stimulatns, uppers, downers, anti-depressants, anti-pshychotic mediations, Prozac, sedatives. The findings are based on data for all patients under the age of 20 in British Columbia.
According to a recent study, one in eight Americans are socially phobic. The New Republic examines how this epidemic of social phobia was fostered by an expanded definition of the disorder and a push from drug companies who stand to make a big profit from new medications such as Paxil.